HIV-related bronchiectasis in children: An emerging spectre in high tuberculosis burden areas

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 1, 2012, Pages 114-119

  Masekela, Refiloe ^a   Anderson, R ^b   Moodley, T ^a   Kitchin, O P ^a   Risenga, S M ^a   Becker, P J ^c   Green, R J ^a  

^a STEVE BIKO ACADEMIC HOSPITAL   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Bronchiectasis; Cytokines; Human immunodeficiency virus; Paediatrics; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TOBACCO SMOKE; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ADOLESCENT; ARTICLE; ATOPY; BACTERIUM CULTURE; BLOOD SAMPLING; BRONCHIECTASIS; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; DEMOGRAPHY; DEVELOPING COUNTRY; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INFORMATION PROCESSING; MALE; MICROBIOLOGICAL EXAMINATION; MORBIDITY; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 2; PARAINFLUENZA VIRUS 3; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SCHOOL CHILD; SPIROMETRY; SPUTUM SMEAR; TUBERCULOSIS; VIRUS CULTURE;

ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTERIOLOGICAL TECHNIQUES; BRONCHIECTASIS; CHILD; COINFECTION; CYTOKINES; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; IMMUNOLOGIC TESTS; INFLAMMATION MEDIATORS; MYCOBACTERIUM TUBERCULOSIS; RISK ASSESSMENT; RISK FACTORS; SOUTH AFRICA; SPIROMETRY; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 84555177574     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0244     Document Type: Article

References (42)

1. Klugman K P. Emerging infectious diseases - South Africa. Emerg Infect Dis 1998; 4: 517-520.
2. Statistics South Africa. Mortality and causes of death in South Africa 2005: findings from death notification. Pretoria, South Africa: StatsSA, 2005. http://www.statssa.gov.za Accessed September 2011.
3. Avert. South Africa HIV and AIDS statistics. Horsham, UK: Avert, 2011. http://www.avert.org/safricastats.htm Accessed September 2011.
4. Department of Health, South Africa. Dual therapy for PMTCT to start early next year. Pretoria, South Africa: DoH, 2007. http://www.doh.gov.za/docs/pr/ 2007/index.html Accessed September 2011.
5. Connor E M, Sperling R S, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-1180.
6. Spira R, Lepage P, Msellati P, et al. Natural history of human immunodeficiency virus type-1 infection in children. A five-year prospective study in Rwanda. Mother-to-child HIV-1 Transmission Study Group. Paediatrics 1999; 104: e56.
7. Jeena P M, Coovadia H M, Thula S A, Blythe D, Buckels N J, Chetty R. Persistent and chronic lung disease in HIV-infected and un-infected African children. AIDS 1998; 12: 1183-1193.
8. Zar H J. Chronic lung disease in human immunodeficiency virus (HIV) infected children. Pediatr Pulmonol 2008; 43: 1-10.
9. Stokes D C. Pulmonary infections in the immunocompromised paediatric host. In: Chernick V, Boat T F, Wilmott R W, Bush A, eds. Kendig's disorders of the respiratory tract in children. Philadelphia, PA, USA: Saunders Elsevier, 2006: pp 453-462.
10. Field C E. Bronchiectasis. Third report on follow up of medical and surgical cases from childhood. Arch Dis Child 1969; 44: 551-561.
11. Goemine P, Dupont L. Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century. Postgrad Med J 2010; 86: 493-501.
12. Singleton R, Morris A, Redding G, et al. Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatr Pulmonol 2000; 29: 182-189.
13. Twiss J, Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis 'too high' for a developed country. Arch Dis Child 2005; 90: 737-740.
14. Chang A B, Grimwood K, Mulholland E K, et al. Bronchiectasis in indigenous children in remote Australian communities. Med J Aust 2002; 177: 200-204.
15. Zhang L, Irion K, da Silva Porto N, Abreu e Silva F. High-resolution computed tomography in paediatric patients with post-infectious bronchiolitis obliterans. J Thorac Imaging 1999; 14: 85-89.
16. Sheikh S, Madiraju K, Steiner P, Madi R. Bronchiectasis in pediatric AIDS. Chest 1997; 112: 1202-1207.
17. Holmes A, Trotman-Dickenson B, Edwards A, et al. Bronchiectasis in HIV disease. Q J Med 1992; 85: 875-882.
18. Van Rie A, Beyers N, Gie R P, Kunneke M, Zeitsman L, Donald P R. Childhood tuberculosis in an urban population in South Africa: burden and risk factors. Arch Dis Child 1999; 80: 433-437.
19. Lazarus J V, Olsen M, Ditiu L, Matics S. Tuberculosis-HIV co-infection: policy and epidemiology in 25 countries in WHO European region. HIV Med 2008; 9: 406-414.
20. Coovadia H M, Jeena P, Wilkinson D. Childhood human immunodeficiency virus and tuberculosis co-infections: reconciling conflicting data. Int J Tuberc Lung Dis 1998; 2: 844-851.
21. Bonfield T L, Panushka J R, Konstan M W, Hilliard J B, Ghnaim H, Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152: 2111-2118.
22. Berman D M, Mafut D, Kjokic B, Scott G, Mitchell C. Risk factors for the development of bronchiectasis in HIV-infected children. Pediatr Pulmonol 2007; 42: 871-875.
23. Callahan C W, Redding G J. Bronchiectasis in children. Orphan disease or persistent problem? Pediatr Pulmonol 2002; 33: 492-496.
24. Von Gottberg A, de Gouveia L, Madhi S A, et al. Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Bull World Health Organ 2006; 84: 811-818.
25. Madhi S A, Petersen K, Khoosa M, et al. Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatr Infect Dis J 2002; 21: 315-321.
26. McNally L M, Jeena P M, Gajee A, et al. Lack of association between the nasopharyngeal carriage of Streptococcus pneumonia and Staphylococcus aureus in HIV-1 infected South African children. J Infect Dis 2006; 194: 385-390.
27. Theart A C, Marais B J, Gie R P, Hesseling A C, Beyers N. Criteria used for the diagnosis of childhood tuberculosis at primary health care level in a high-burden, urban setting. Int J Tuberc Lung Dis 2005; 9: 1210-1214.
28. Munro K A, Reed P W, Joyce H, et al. Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression? Pediatr Pulmonol 2011; 46: 131-138.
29. Chang A B, Grimwood K, Maguire G, King P T, Morris P S, Torzillo P J. Management of bronchiectasis and chronic suppurative lung disease in indigenous children and adults from rural and remote Australian communities. Med J Aust 2008; 189: 386-393.
30. Bacot B K, Paul M E, Navarro M. Objective measures of allergic disease in children with human immunodeficiency virus infection. J Allergy Clin Immunol 1997; 100: 707-711.
31. Vigano A, Principi N, Crupi L, Onorato J, Vincenza Z G, Selvaggio A. Elevation of IgE in HIV-infected children and its correlation with progression of disease. J Allergy Clin Immunol 1995; 95: 627-632.
32. Empson M, Bishop A G, Nightingale B, Garsia R. Atopy, anergic status, cytokine expression in HIV-infected subjects. J Allergy CIin Immunol 1999; 103: 833-842.
33. Clerici M, Shearer G M. The Th1-Th2 switch is critical in the etiology of HIV-infection. Immunol Today 1993; 14: 107-111.
34. Liu Z, Liu W, Pesce J, et al. Requirements for the development of IL-4 producing T cells during intestinal nematode infections: what it takes to make a TH2 cell in vivo. Immunol Rev 2004; 201: 57-74.
35. Patella V, Florio G, Petraroli A, Marone G. HIV-1 gp120 cytokines induces IL-4 and IL-13 release from human Fc epsilon R+ cells through interaction with VH3 region of IgE. J Immunol 2000; 164: 589-595.
36. Masekela R, Moodley T, Mahlaba N, Wittenberg D F, Green R J. Atopy in human immunodeficiency virus infected children in South Africa. S Afr Med J 2009; 99: 822-825.
37. Zar H J, Latief Z, Hughes J, Hussey G. Serum immunoglobulin E levels in human immunodeficiency virus-infected children with pneumonia. Pediatr Allergy Immunol 2002; 13: 328-333.
38. Saiman L. Microbiology of early CF lung disease. Paediatr Resp Reviews 2004; 5 (Suppl): S367-S369.
39. Bartling T R, Drumm M L. Oxidative stress causes IL-8 promoter hyperacetylation in cystic fibrosis airway cell models. Am J Resp Cell Mol Biol 2009; 40: 58-65.
40. Feldman J G, Minkoff H, Schneider M F, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health 2006; 96: 1060-1065.
41. Masekela R, Labuschagne D, Moodley T, Kitchin O P, Green R J. HIV staging and severity of AIDS in children exposed to environmental tobacco smoke. Chest 2008; 134: 139002S.
42. Kabali C, Cheng D M, Brooks C, Horsburgh R Jr, Samet J H. Recent cigarette smoking and HIV disease progression: no evidence of an association. AIDS Care 2011; 10: 1-10.